Annexon Correlations
ANNX Stock | USD 5.27 0.12 2.23% |
The current 90-days correlation between Annexon and VectivBio Holding AG is 0.04 (i.e., Significant diversification). The correlation of Annexon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Annexon Correlation With Market
Weak diversification
The correlation between Annexon and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and DJI in the same portfolio, assuming nothing else is changed.
Annexon |
Moving together with Annexon Stock
0.65 | DNTH | Dianthus Therapeutics | PairCorr |
0.73 | VIGL | Vigil Neuroscience | PairCorr |
0.8 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
Moving against Annexon Stock
0.61 | VCEL | Vericel Corp Ord | PairCorr |
0.51 | DRTS | Alpha Tau Medical Trending | PairCorr |
0.31 | VCYT | Veracyte | PairCorr |
0.68 | DYAI | Dyadic International | PairCorr |
0.48 | VTVT | vTv Therapeutics | PairCorr |
0.47 | VTRS | Viatris | PairCorr |
0.39 | VNDA | Vanda Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Annexon Stock performing well and Annexon Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Annexon's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IMMX | 4.35 | (0.06) | (0.01) | 0.07 | 4.54 | 9.38 | 32.68 | |||
CNSP | 4.45 | (0.36) | 0.00 | (0.28) | 0.00 | 9.09 | 39.29 | |||
HEPA | 3.85 | (0.42) | 0.00 | (0.13) | 0.00 | 8.06 | 33.54 | |||
FRLN | 5.90 | 0.06 | 0.00 | 0.07 | 0.00 | 14.23 | 72.38 | |||
AVRO | 1.77 | 0.06 | 0.01 | 0.21 | 1.89 | 4.11 | 14.20 | |||
DAWN | 2.03 | (0.05) | (0.03) | 0.05 | 2.73 | 3.84 | 11.44 | |||
ABOS | 3.58 | (0.48) | 0.00 | (0.06) | 0.00 | 7.52 | 28.07 | |||
XFOR | 5.11 | (0.54) | 0.00 | (0.26) | 0.00 | 8.82 | 62.35 | |||
INZY | 2.78 | (1.17) | 0.00 | (0.60) | 0.00 | 5.07 | 16.62 | |||
VECT | 2.63 | 1.16 | 0.54 | (2.61) | 0.88 | 5.61 | 39.30 |
Annexon Corporate Management
Shikhar MBA | Senior Commercial | Profile | |
Arnon Rosenthal | Founder | Profile | |
Michael MBA | Executive Officer | Profile | |
Mirella Toro | Sec | Profile | |
Ted Yednock | Chief VP | Profile | |
HenkAndre MD | Senior Medicine | Profile |